Research
Hormonal
The total daily dose (TDD) of insulin decreased from 183 ± 98 units to 143 ± 99 units over 6 months (P < 0.001).
Clinicians may consider semaglutide as a viable option to reduce insulin requirements in T2DM patients.
StrongSupportsmedium confidence
the TDD of insulin decreased from baseline to 6 months (183 ± 98 units and 143 ± 99 units, P < 0.001).
Why this rating
Based on the retrospective medical record review of 72 patients.
Source
The Effects of Adding Semaglutide to High Daily Dose Insulin Regimens in Patients With Type 2 Diabetes
Jodi Meyer et al. · Annals of Pharmacotherapy · 2022
other · n=72Cited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →